APA (7th ed.) Citation

Le Bourdonnec, B., Windh, R. T., Leister, L. K., Zhou, Q. J., Ajello, C. W., Gu, M., . . . Dolle, R. E. (2009). Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-3-hydroxy-4-(spiro[chromene-2,4′-piperidine]-4-yl) Benzamide (ADL5747). Journal of medicinal chemistry, 52(18), 5685-5702. https://doi.org/10.1021/jm900773n

Chicago Style (17th ed.) Citation

Le Bourdonnec, Bertrand, et al. "Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-3-hydroxy-4-(spiro[chromene-2,4′-piperidine]-4-yl) Benzamide (ADL5747)." Journal of Medicinal Chemistry 52, no. 18 (2009): 5685-5702. https://doi.org/10.1021/jm900773n.

MLA (9th ed.) Citation

Le Bourdonnec, Bertrand, et al. "Spirocyclic Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N,N-Diethyl-3-hydroxy-4-(spiro[chromene-2,4′-piperidine]-4-yl) Benzamide (ADL5747)." Journal of Medicinal Chemistry, vol. 52, no. 18, 2009, pp. 5685-5702, https://doi.org/10.1021/jm900773n.